Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01219647 · ClinicalTrials.gov registry record · Phase 1

Exercise as a Strategy to Treat Cognitive Dysfunction in Persons With Multiple Sclerosis

A Phase 1 study of Multiple Sclerosis, sponsored by University of California, Los Angeles.

Completed
Registry status
Phase 1
Development phase
35
Enrollment target
2
Study locations

NCT01219647 is a Phase 1 study of Multiple Sclerosis that has completed, run by University of California, Los Angeles. The registered enrollment target is 35 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01219647, a Phase 1 study of Multiple Sclerosis, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
Phase 1
Development phase
35 participants
Enrollment target
2
Study locations

Study Summary

Many persons with Multiple Sclerosis ( MS) have problems with memory and thinking.Exercise has been shown to improve memory and thinking in persons with diseases such as Alzheimer's. This study will investigate whether a program of aerobic exercise can improve memory and thinking in persons with MS

Conditions Studied

Interventions

  • BEHAVIORAL stretching
  • BEHAVIORAL exercise

Study Locations (2)

California

  • UCalifornia at Los Angeles - Los Angeles
  • CAl State University at Northridge - Northridge

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2010-07
Est. Completion 2014-08
Phase Phase 1

What the Registry Record Tells You About NCT01219647

The ClinicalTrials.gov registry entry for NCT01219647 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (94% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 2 interventions - of which stretching is the first listed.

NCT01219647 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01219647 about?

NCT01219647 is a clinical study titled "Exercise as a Strategy to Treat Cognitive Dysfunction in Persons With Multiple Sclerosis". Many persons with Multiple Sclerosis ( MS) have problems with memory and thinking.Exercise has been shown to improve memory and thinking in persons with diseases such as Alzheimer's. This study will investigate whether a program of aerobic exercise can improve memory and thinking in persons with MS

What is the current status of trial NCT01219647?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 35 participants. The study started on 2010-07. Estimated completion is 2014-08.

What conditions does trial NCT01219647 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

What interventions are being tested in trial NCT01219647?

The interventions under investigation include: stretching (BEHAVIORAL), exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT01219647?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01219647 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.